Last update 08 May 2025

CTNNB x CLEC-2

Basic Info

Related Targets
CTNNBCLEC-2

Related

1
Drugs associated with CTNNB x CLEC-2
Fucoidan
Target
CLEC-2 x CTNNB
Mechanism
CLEC-2 agonists [+1]
Active Org.
Taipei Medical UniversityTaipei Medical University [+2]
Originator Org.
Jiangsu Provincial People's Hospital
Active Indication
Helicobacter pylori infection [+3]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
35
Clinical Trials associated with CTNNB x CLEC-2
CTRI/2025/04/085615
/ Not yet recruitingPhase 2IIT
A Randomized Controlled Split Mouth Clinical Trial Comparing the Effect of Fucoidan Hydrogel with Xenograft to Xenograft Alone on Periodontal Regeneration in Mandibular Grade II Furcation Defects - FUCO-PERIO trial
CTRI/2024/07/071419
/ RecruitingPhase 4
A randomized, double-blind, placebo-controlled study to assess the effect of fucoidan on prostate health in males with benign prostatic hyperplasia - NIL
RPCEC00000443
/ CompletedPhase 1IIT
Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome
100 Clinical Results associated with CTNNB x CLEC-2
Login to view more data
100 Translational Medicine associated with CTNNB x CLEC-2
Login to view more data
0 Patents (Medical) associated with CTNNB x CLEC-2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free